Latest News and Press Releases

PALATINE, IL--(Marketwired - July 01, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced it has entered into a Securities Purchase Agreement with certain institutional investors to...

PALATINE, IL--(Marketwired - June 29, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced receipt from the United...

PALATINE, IL--(Marketwired - June 16, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced that Acura has entered into a License and Development Agreement with Bayer Healthcare LLC to...

PALATINE, IL--(Marketwired - May 04, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...

PALATINE, IL--(Marketwired - April 21, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs,  today announced that the Company plans...

PALATINE, IL--(Marketwired - April 09, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR), announced today that it is initiating development of an immediate-release hydrocodone bitartrate with...

PALATINE, IL--(Marketwired - March 23, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced preliminary topline results from a pilot clinical study which demonstrated bioequivalence of...

PALATINE, IL--(Marketwired - March 02, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...

PALATINE, IL--(Marketwired - February 23, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...

PALATINE, IL--(Marketwired - February 16, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced the initiation of treatment in a pilot clinical study of two experimental formulations of...